News

US Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly claimed in public statements that most vaccines ...
Artificial blood could reduce preventable deaths in settings where limited supply costs millions of lives in low-income ...
Elon Musk’s Neuralink isn’t the only contender in the brain-tech race. Paradromics has entered the arena with its first human brain-computer interface (BCI) implant. The neurotechnology startup on ...
Elon Musk's brain-computer interface startup Neuralink secured $650 million in series E funding to expand patient access to ...
Stem cells can fight disease from the inside out. But spas and clinics are selling treatments that are unproven, expensive, ...
While all groups have demonstrated an inspiring level of dedication and passion, I have always been moved by patients’ ...
Biopharmaceutical companies routinely cure diseases in animals during preclinical testing, yet those same therapies fail in ...
This year marks an important turning point for brain-computer interface development in China as clinical trials get underway.
Neuralink accelerates its brain-computer interface ambitions with a major funding boost and ongoing human trials.
Phase 2 data expected in 2H 2026 - - KPL-387 Phase 1 single ascending dose data support profile for monthly dosing - LONDON, ...
Maxiom Labs, Inc. (MAXIOM) officially launched its revolutionary AI platform designed to optimize health, fitness, and performance-for committed athletes and everyday achievers alike. After months of ...
Sanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.